154 related articles for article (PubMed ID: 10073560)
1. High-dose therapy for breast cancer.
Hudis CA; Münster PN
Semin Oncol; 1999 Feb; 26(1):35-47. PubMed ID: 10073560
[TBL] [Abstract][Full Text] [Related]
2. Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer.
Myers SE; Williams SF
Hematol Oncol Clin North Am; 1993 Jun; 7(3):631-45. PubMed ID: 8102137
[TBL] [Abstract][Full Text] [Related]
3. [State of the art of drug therapy in breast cancer].
Watanabe T
Gan To Kagaku Ryoho; 1993 Dec; 20(16):2437-46. PubMed ID: 8279839
[TBL] [Abstract][Full Text] [Related]
4. High-dose therapy in breast cancer: out of favor but not out of promise.
Glück S; Stewart D
Bone Marrow Transplant; 2000 May; 25(10):1017-9. PubMed ID: 10828859
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation in the treatment of breast cancer: clinical and technologic strategies.
Vaughan WP
Semin Oncol; 1993 Oct; 20(5 Suppl 6):55-8. PubMed ID: 8211216
[TBL] [Abstract][Full Text] [Related]
6. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
7. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
8. Relevance of high-dose chemotherapy in solid tumours.
Nieboer P; de Vries EG; Mulder NH; van der Graaf WT
Cancer Treat Rev; 2005 May; 31(3):210-25. PubMed ID: 15944050
[TBL] [Abstract][Full Text] [Related]
9. [Dose density and dose intensity in the treatment of breast cancer].
Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP
Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616
[TBL] [Abstract][Full Text] [Related]
10. [High-dose chemotherapy and autologous bone marrow transplantation in solid tumors. A review].
Handberg J; Hansen SW
Ugeskr Laeger; 1996 Jul; 158(29):4175-80. PubMed ID: 8701532
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
[TBL] [Abstract][Full Text] [Related]
12. The verdict is not in yet. Analysis of the randomized trials of high-dose chemotherapy for breast cancer.
Nieto Y
Haematologica; 2003 Feb; 88(2):201-11. PubMed ID: 12604410
[TBL] [Abstract][Full Text] [Related]
13. Dose-dense chemotherapy for primary breast cancer.
Kümmel S; Rezai M; Kimmig R; Schmid P
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
[TBL] [Abstract][Full Text] [Related]
14. [High-dose chemotherapy for metastatic breast cancer].
Lalle M; De Rosa L; Perillo A; Scambia G; D'Aprile M; Antimi M
Clin Ter; 2004; 155(7-8):305-15. PubMed ID: 15553258
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
16. The randomized trials of dose-intensive therapy for breast cancer: what do they mean for patient care and where do we go from here?
Weiss RB
Oncologist; 1999; 4(6):450-8. PubMed ID: 10631689
[TBL] [Abstract][Full Text] [Related]
17. Randomized trials of high-dose chemotherapy in breast cancer: fraud, the press and the data (or lessons learned in medical policy governing clinical research).
Antman K
Trans Am Clin Climatol Assoc; 2002; 113():56-66; discussion 66-7. PubMed ID: 12053718
[TBL] [Abstract][Full Text] [Related]
18. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
19. Current limits of knowledge in adjuvant and neoadjuvant endocrine therapy of breast cancer: the need for more clinical research.
Hayward RL; Dixon JM
Surg Oncol; 2003 Dec; 12(4):289-304. PubMed ID: 14998569
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy in ovarian carcinoma.
Herrin VE; Thigpen JT
Semin Oncol; 1999 Feb; 26(1):99-105. PubMed ID: 10073566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
